Boyu Capital

Active

Website LinkedIn

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jul 19, 2023	Farizon Auto	$600.0M Series A	Boyu Capital	Hidden Hill Capital, Industry Foundation of Xiangtan, Linjiang Industry Group, United Clean Energy
Sep 8, 2022	Animoca Brands	$110.0M Other Equity	Boyu Capital, GGV Capital, Temasek	Mirae Asset, True Global Ventures
Jun 1, 2022	Frontera Therapeutics	$160.0M Series B	—	Atlas Venture, Bessemer Venture Partners, Creacion Ventures, Hongshan Capital Group (Sequoia Capital China), Carl Gordon
Sep 3, 2021	XSKY Data Technology	$110.0M Series E	Boyu Capital	—
Aug 17, 2021	Meditrust	$308.7M Series C	Boyu Capital, Janchor Partners	AIHC Capital, Bank of China Group Investment, China Everbright, China Renaissance, CICC Capital, Lake Bleu Capital, Lilly Asia Ventures, Marathon Venture Partners, New Alliance Capital, Shanghai Biopharmaceutical Fund, Sinovation Ventures
Aug 3, 2021	Pulse	$100.0M Series C	Hillhouse Capital, 何国伟	Haoyue Capital, Insight Capital
Jan 22, 2021	4Paradigm	$700.0M Series D	Boyu Capital, Primavera Capital Group	CPE, FountainVest Partners, Haitong Securities, Hongshan Capital Group (Sequoia Capital China), Jianyin International Capital Management (Tianjin)
Dec 1, 2020	SciNeuro	$100.0M Series A	ARCH Venture Partners, Judith Li	Sequoia Capital China, General Atlantic, Hongshan Capital Group (Sequoia Capital China), TF Capital, Zoo Capital
Nov 17, 2020	D3 Bio	$200.0M Series A	—	Yanling Cao, Hongshan Capital Group (Sequoia Capital China), Matrix Partners China, Temasek, WuXi AppTec
Oct 26, 2020	Yuanfudao	$2.2B Series G	DST Global, Tencent	CPE, Danhe Capital, DCP Capital, GIC, Greenwoods, Hillhouse Capital, IDG Capital, Ocean Link, TBP, Temasek
Jul 1, 2020	Antengene Corporation	$97.0M Series C	Fidelity Management & Research Company	Qiming Venture Partners, GIC
Mar 1, 2020	Yuanfudao	$1.0B Series G	Hillhouse Capital Group, Tencent	Griffin Gaming Partners, IDG Capital
Jun 13, 2019	Waterdrop	$144.5M Series C	Boyu Capital	—
Jan 1, 2019	Antengene Corporation	$120.0M Series B	Boyu Capital, FountainVest Partners	Qiming Venture Partners, Celgene, Taikang, TF Capital, WuXi AppTec
Jul 2, 2018	Trax	$125.0M Series E	Joey Chen	DC Thomson, Investec, Warburg Pincus
May 24, 2018	Brii Biosciences	$260.0M Other Equity	—	Leon Chen, Robert Nelsen, Blue Pool Capital, Sean Tong, Neil Shen, David Yu
May 16, 2018	FogPharma	$66.0M Series B	Leon Chen	Blue Pool Capital, Deerfield Management, Krishna Yeshwant, Horizons Ventures, Leerink Partners, Nan Fung Group, WuXi AppTec
May 9, 2018	CStone Pharmaceuticals	$259.2M Series B	GIC	3W Partners, 6 Dimensions Capital, ARCH Venture Partners, AVICT Global, CPE, Hillhouse Capital, Hongshan Capital Group (Sequoia Capital China), King Star Capital, Taikang, Terra Magnum Capital Partners, WuXi Healthcare Ventures, Yunfeng Capital
Feb 1, 2018	Viela Bio	$280.0M Series A	—	6 Dimensions Capital, Yanling Cao, Michael Yi, Sirona Capital, Temasek
Sep 1, 2017	LifeMine Therapeutics	$70.0M Series A	Edward Hu	Aisling Capital, ARCH Venture Partners, Foresite Capital, F-Prime Capital Partners, GV, Mubadala, Alexandria Venture Investments, Blue Pool Capital, Yanling Cao, M Ventures
Jul 4, 2016	CStone Pharmaceuticals	$146.5M Series A	—	WuXi Healthcare Ventures